TOKYO -- A Japanese team testing the flu drug Avigan as a treatment for the new coronavirus said Wednesday more time was needed to determine its effectiveness, while the government stood by a goal of approving the medication's use this month.
Pharmaceuticals
Avigan trials will continue in Japan, with drug efficacy unclear
University seeks evidence as Abe government stands by goal of May approval
Data showing the effectiveness of Avigan (generic name: Favipiravir) would need to come forward within the next several days to meet the May approval target. © Reuters
Read Next
Latest on Pharmaceuticals
